 Diabetic nephropathy now accounts for 20 to 40 of all patients entering end-stage renal failure ESRF programs. The quality of glycemic control is known to be an important determinant of the rate of progression of patients with diabetic continuous ambulatory peritoneal dialysis CAPD patients. Diabetic CAPD patients are usually treated with dialysis fluids utilizing glucose as the osmotic agent to provide ultrafiltration. Most of diabetic CAPD patients had HbA1c readings above 7 despite the recommendation to keep the reading below 7. 